Atlas Trials

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Clinical trial NCT03229278 · COMPLETED

Trial details

NCT number
NCT03229278
Sponsor
Rutgers, The State University of New Jersey
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
LymphomaMetastatic Malignant Solid NeoplasmMetastatic MelanomaMetastatic Renal Cell CancerRecurrent Bladder CarcinomaRecurrent Classical Hodgkin LymphomaRecurrent Head and Neck Squamous Cell CarcinomaRecurrent LymphomaRecurrent Malignant Solid NeoplasmRecurrent Renal Cell CarcinomaStage III Bladder CancerStage III Lymphoma
Start date
2017-10-03
Primary completion
2022-10-20
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.